Lundbeck’s drug portfolio faces patent expirations but shows growth potential. Find out why HLBBF stock could see upside with ...

Approximately $50.0 million of net revenue from sales of LUMRYZ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients ...

Bilfinger (BFLBF) is well-positioned to benefit from strong secular trends. Read more to see why I rate the stock a buy.

LUMRYZ, is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in ...

Schwan said on the company's results call that it is bracing for a CHF 5 billion loss in COVID sales this year across pharma and diagnostics on weaker demand. There was already some evidence for ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Marks & Spencer CEO Stuart Machin insisted the high street retailer – which reported a 1% year-on-year rise in clothing and ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,21,193.59 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

LANTA announced on its website that it will close the transit center near the entrance to Boscov's in June at the request of mall management.